Filing Details

Accession Number:
0000711377-14-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-14 16:05:25
Reporting Period:
2014-05-12
Filing Date:
2014-05-14
Accepted Time:
2014-05-14 16:05:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-12 4,500 $18.68 894,613 No 4 M Direct
Common Stock Disposition 2014-05-12 2,000 $38.11 892,613 No 4 S Direct
Common Stock Disposition 2014-05-12 2,500 $38.71 890,113 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2014-05-12 4,500 $0.00 4,500 $18.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
358,250 2015-08-24 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 378,480 Indirect See Footnote
Footnotes
  1. Options were granted on 8/24/2010, vest 20% annually on the anniversary date of the grant, and expire on 8/24/2015
  2. 180,000 shares are held in a limited liability corporation, of which mr. Herbert is the sole owner, and 198,480 are held in trust for mr. Herbert's spouse